Answers are grounded in this paper and cite their sources.
Summary Primary matched analysis showed no statistically distinguishable excess one‐year asthma exacerbation risk with coded ABPA. Biomarker‐independent and recent‐ABPA analyses were consistent; exploratory steroid and pneumonia findings require caution.
No takes yet. Share an insight, caveat, or question.
Nasrullah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: